Holen Sie sich die Stockscreener-App
0.6552
0.34%
0.0022
Vorhandelsmarkt:
.67
0.0148
+2.26%
Schlusskurs vom Vortag:
$0.653
Offen:
$0.6382
24-Stunden-Volumen:
7.39M
Relative Volume:
1.19
Marktkapitalisierung:
$76.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-119.76M
KGV:
-0.4853
EPS:
-1.35
Netto-Cashflow:
$-55.17M
1W Leistung:
+2.41%
1M Leistung:
-25.55%
6M Leistung:
-87.25%
1J Leistung:
-74.20%
1-Tages-Spanne:
$0.61
$0.75
1-Wochen-Bereich:
$0.606
$0.75
52-Wochen-Spanne:
$0.6016
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Firmenname
Applied Therapeutics Inc
Sektor
Branche
Telefon
212-220-9226
Adresse
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Vergleichen Sie APLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.6552 | 76.24M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-23 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | Eingeleitet | William Blair | Outperform |
| 2024-03-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-22 | Eingeleitet | Leerink Partners | Outperform |
| 2022-01-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-08-27 | Herabstufung | Goldman | Neutral → Sell |
| 2021-06-25 | Fortgesetzt | Goldman | Neutral |
| 2020-10-08 | Eingeleitet | Truist | Buy |
| 2020-04-22 | Eingeleitet | Goldman | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-06-10 | Eingeleitet | Citigroup | Buy |
| 2019-06-10 | Eingeleitet | Cowen | Outperform |
| 2019-06-10 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Applied Therapeutics Inc Aktie (APLT) Neueste Nachrichten
Hennion & Walsh Asset Management Inc. Raises Position in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
Applied Therapeutics, Inc. (NASDAQ:APLT) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - GlobeNewswire Inc.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAPLT - PR Newswire
Applied Therapeutics, Inc. (APLT) Investors: February 18, - GlobeNewswire
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - GlobeNewswire Inc.
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
2025-01-21 | Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:APLT | Press Release - Stockhouse Publishing
Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality - The Manila Times
Applied Therapeutics Strengthens Leadership Team with New Quality Control VP Appointment - StockTitan
Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update - Defense World
2025-01-20 | Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
2025-01-20 | Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Kessler Topaz Meltzer & Check, LLP Notifies Applied Therapeutics, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit - Marketscreener.com
Short Interest in Applied Therapeutics, Inc. (NASDAQ:APLT) Grows By 5.6% - MarketBeat
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
2025-01-19 | Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:APLT | Press Release - Stockhouse Publishing
2025-01-19 | Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - Newsfile
2025-01-19 | Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
2025-01-18 | Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
ROSEN, A HIGHLY RECOGNIZED FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure - The Bakersfield Californian
ROSEN, A HIGHLY RECOGNIZED FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
APLT Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of February 18, 2025 Deadline in Securities Fraud Class Action Lawsuit Against Applied Therapeutics, Inc. (APLT) - The Malaysian Reserve
2025-01-17 | Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky about Pending Class ActionAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
2025-01-17 | Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
2025-01-17 | APLT FRAUD ALERT: Applied Therapeutics Sued after Stock Drops 80%Investors with Losses are Urged to Contact BFA Law before February 18 Class Action Deadline | NDAQ:APLT | Press Release - Stockhouse Publishing
Faruqi & Faruqi Reminds Applied Therapeutics Investors of - GlobeNewswire
Faruqi & Faruqi Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - GlobeNewswire Inc.
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for InvestorsContact Levi & Korsinsky - Stockhouse Publishing
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT) - Stockhouse Publishing
2025-01-16 | Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Kessler Topaz Meltzer & Check, LLP Encourages Applied Therapeutics, Inc. (APLT) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit - Marketscreener.com
The Gross Law Firm Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied - GlobeNewswire
Applied Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
Complete Response Letter, Warning Letter and Shareholder Lawsuit Follow FDA Data Integrity Findings - JD Supra
2025-01-15 | APLT COURT REMINDER: The February 18 Deadline in the Applied Therapeutics Class Action is ApproachingInvestors are Reminded to Contact BFA Law | NDAQ:APLT | Press Release - Stockhouse Publishing
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. Investors to Secure - The Bakersfield Californian
2025-01-15 | Investors who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
2025-01-15 | Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionAPLT - Markets Insider
2025-01-14 | Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:APLT | Press Release - Stockhouse Publishing
Applied Therapeutics, Inc. Investors: Please contact the - GlobeNewswire
Applied Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your ... - The Bakersfield Californian
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - Stockhouse Publishing
Finanzdaten der Applied Therapeutics Inc-Aktie (APLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):